3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATING PROTEIN KINASE ACTIVITY AND FOR USE IN CANCER CHEMOTHERAPY - Patent 1139754

(19)

(11)

EP 1 139 754 A1

(12)

(43)	Date of publication:
	10.10.2001 Bulletin 2001/41

(21)	Application number: 99966725.6

(22)	Date of filing: 30.12.1999

(51)	International Patent Classification (IPC)⁷: A01N 43/38, A61K 31/40

(86)	International application number:
	PCT/US9931/232

(87)	International publication number:
	WO 0038/519 (06.07.2000 Gazette 2000/27)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

31.12.1998 US 114313 P

(71)	Applicant: Sugen, Inc.
	South San Francisco, CA 94080-4811 (US)

(72)	Inventors:
	LANGECKER, Peter, J. Monte Sereno, CA 95030 (US) SHAWVER, Laura, Kay San Francisco, CA 94112 (US) TANG, Peng, Cho Moraga, CA 94556 (US) SUN, Li Foster City, CA 94404 (US)

(74)	Representative: Viering, Jentschura & Partner
	Postfach 22 14 43 80504 München 80504 München (DE)

(54)	3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATING PROTEIN KINASE ACTIVITY AND FOR USE IN CANCER CHEMOTHERAPY